Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Cytokinetics Insider Sold Shares Worth $490,950, According to a Recent SEC Filing

Cytokinetics Insider Sold Shares Worth $490,950, According to a Recent SEC Filing

MT newswireMT newswire2026/09/28 20:58
04:58 PM EDT, 09/28/2026 (MT Newswires) -- Robert I Blum, Director, President & CEO, on September 28, 2026, sold 7,500 shares in Cytokinetics (CYTK) for $490,950. Following the Form 4 filing with the SEC, Blum has control over a total of 282,710 common shares of the company, with 278,544 shares held directly and 4,166 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1061983/000106198326000097/xslF345X05/form4.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!